King Assures Investors Embeda Marketing Materials Not Lost In DDMAC "Black Hole"
This article was originally published in The Pink Sheet Daily
Executive Summary
Five months after the launch of King's oral morphine Embeda, execs still await FDA approval of marketing materials.